BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37795894)

  • 1. The Reduction of the Cell Nuclear Size in the Cell Body Space During the Differentiation Might Be Cell Lineage Specific (A Retrospective Morphological Note).
    Smetana K; Klamová H; Mikulenková D; Karban J; Trněný M
    Physiol Res; 2023 Aug; 72(4):521-524. PubMed ID: 37795894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cell body space occupied by the nucleus during the cell differentiation in human lymphocytic, granulocytic and erythroid cell lineages.
    Smetana K; Klamová H; Mikulenková D; Čermák J; Otevřelová P; Karban J; Trněný M
    Physiol Res; 2021 Nov; 70(5):701-707. PubMed ID: 34505521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To the approximate size of the nuclear region occupied by nucleolar bodies during cell differentiation and maturation using the human leukemic granulocytic lineage as a convenient model.
    Smetana K; Klamová H; Mikulenková D
    Physiol Res; 2019 Aug; 68(4):633-638. PubMed ID: 31177792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of chronic lymphocytic leukemia in patients with chronic myelogenous leukemia.
    Bhattacharyya PK
    Indian J Pathol Microbiol; 2013; 56(3):188-9. PubMed ID: 24152491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Myelogenous Leukemia Diagnosed in the Setting of Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
    Viswanathan K; Roboz G; Chadburn A; Mathew S
    Int J Surg Pathol; 2020 Apr; 28(2):216-224. PubMed ID: 31544558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous occurrence of B-cell chronic lymphocytic leukemia and chronic myeloid leukemia with further evolution to lymphoid blast crisis.
    Esteve J; Cervantes F; Rives S; Rozman M; Zarco MA; Montserrat E
    Haematologica; 1997; 82(5):596-9. PubMed ID: 9407730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. To the Nuclear Region Occupied by Nucleolar Bodies in Human Leukaemic Myeloblasts of Kasumi 1 and K 562 Lineages.
    Smetana K; Otevřelová P; Kuželová K; Zápotocký M
    Folia Biol (Praha); 2018; 64(5-6):182-185. PubMed ID: 30938675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of 12-O-tetradecanoylphorbol-13-acetate (TPA) on leukemic cells from chronic B cell leukemia.
    Tokumine Y; Waki K; Nishimori Y; Kuratsune H; Inoue R; Nakamura Y; Ueda E; Machii T; Kitani T
    Leukemia; 1989 Jul; 3(7):516-21. PubMed ID: 2786598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. To the nucleolar bodies (nucleoli) in cells of the lymphocytic lineage in patients suffering from B - chronic lymphocytic leukemia.
    Smetana K; Karban J; Trneny M
    Neoplasma; 2010; 57(6):495-500. PubMed ID: 20845986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three hematologic malignancies in the same patient: chronic lymphocytic leukemia, followed by chronic myeloid leukemia and acute myeloid leukemia.
    Fattizzo B; Radice T; Cattaneo D; Pomati M; Barcellini W; Iurlo A
    Clin Lab; 2014; 60(11):1929-32. PubMed ID: 25648037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific Features of Interactions between Megakaryocytic and Granulocytic Hematopoiesis Lineages and Myelofibrosis during the Acute Phase of Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, and Multiple Myeloma.
    Dolgikh TY; Senchukova SR; Vinogradova EV; Krinitsyna YM
    Bull Exp Biol Med; 2020 Apr; 168(6):734-738. PubMed ID: 32333309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid leukemia differentiation by phorbol ester and retinoic acid: a practical approach.
    Marques-Silva VM; De Souza MH; Teixeira MC; Arcuri RA; Rumjanek VM
    J Clin Lab Anal; 1990; 4(5):342-9. PubMed ID: 2231180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic evolution and lineage histories of chronic lymphocytic leukaemia.
    Gaiti F; Chaligne R; Gu H; Brand RM; Kothen-Hill S; Schulman RC; Grigorev K; Risso D; Kim KT; Pastore A; Huang KY; Alonso A; Sheridan C; Omans ND; Biederstedt E; Clement K; Wang L; Felsenfeld JA; Bhavsar EB; Aryee MJ; Allan JN; Furman R; Gnirke A; Wu CJ; Meissner A; Landau DA
    Nature; 2019 May; 569(7757):576-580. PubMed ID: 31092926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of chronic myeloid leukemia occurring during treatment for chronic lymphocytic leukemia].
    Hattori H; Kuwayama M; Kotake T; Karasuno T
    Gan To Kagaku Ryoho; 2011 Feb; 38(2):333-6. PubMed ID: 21368508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computed tomography textural analysis for the differentiation of chronic lymphocytic leukemia and diffuse large B cell lymphoma of Richter syndrome.
    Reinert CP; Federmann B; Hofmann J; Bösmüller H; Wirths S; Fritz J; Horger M
    Eur Radiol; 2019 Dec; 29(12):6911-6921. PubMed ID: 31236702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous diagnosis of hairy cell leukemia and chronic lymphocytic leukemia/small lymphocytic lymphoma: a frequent association?
    Giné E; Bosch F; Villamor N; Rozman M; Colomer D; López-Guillermo A; Campo E; Montserrat E
    Leukemia; 2002 Aug; 16(8):1454-9. PubMed ID: 12145685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunologic phenotype of lymphocytes in chronic B-cell lymphocytic leukemia. I. B- and T-lymphocytes in chronic lymphocytic leukemia].
    Rupniewska ZM; Wach M; Kowal M; Roliński J; Antosz H
    Acta Haematol Pol; 1992; 23(1):21-7. PubMed ID: 1615748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of chronic lymphocytic leukemia B cells into immunoglobulin secreting cells decreases LEF-1 expression.
    Gutierrez A; Arendt BK; Tschumper RC; Kay NE; Zent CS; Jelinek DF
    PLoS One; 2011; 6(10):e26056. PubMed ID: 21998751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterochromatin density (condensation) during cell differentiation and maturation using the human granulocytic lineage of chronic myeloid leukaemia as a convenient model.
    Smetana K; Mikulenková D; Klamová H
    Folia Biol (Praha); 2011; 57(5):216-21. PubMed ID: 22123464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL.
    Wierzbinska JA; Toth R; Ishaque N; Rippe K; Mallm JP; Klett LC; Mertens D; Zenz T; Hielscher T; Seifert M; Küppers R; Assenov Y; Lutsik P; Stilgenbauer S; Roessner PM; Seiffert M; Byrd J; Oakes CC; Plass C; Lipka DB
    Genome Med; 2020 Mar; 12(1):29. PubMed ID: 32188505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.